BerGenBio — Director's Dealing 2022

Jan 6, 2022

BerGenBio - Mandatory notification of trade by Primary Insiders

Bergen, Norway, 6 January 2022– BerGenBio ASA (OSE: BGBIO) (the "Company"), has been notified that Martin Olin, CEO and primary insider of BerGenBio ASA, has bought 8,000 shares in BerGenBio ASA at an average price of NOK 19.87 per share. After the transaction Mr. Olin holds 8,000 shares in BerGenBio ASA.

Please see the attached document for further details of the transaction.

Contact:

ir@bergenbio.com

Rune Skeie, CFO, BerGenBio ASA rune.skeie@bergenbio.com

This information is subject to the disclosure requirements pursuant to the EU Market Abuse Regulation (MAR) and section 5-12 of the Norwegian Securities Trading Act.